Can MRI make cancer radiation smarter? new study investigates
NCT ID NCT05919290
First seen Mar 22, 2026 · Last updated Jun 23, 2026 · Updated 14 times
Summary
This study is testing whether repeated MRI scans during radiation therapy for head and neck cancer can help doctors see how the tumor is responding. About 173 people with newly diagnosed head and neck cancer will get extra MRI scans during their standard treatment. The goal is to learn if these scans can guide more precise radiation and predict outcomes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEAD AND NECK SQUAMOUS CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Princess Margaret Cancer Centre
RECRUITINGToronto, Ontario, M5G 1X6, Canada
Contact
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could help doctors personalize radiation therapy by using MRI to see how tumors respond during treatment.
What could go wrong
This is an early-stage observational study, not testing a new treatment. It may not lead to changes in standard care.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.